Location History:
- Aberdeen AB15 6DQ, GB (2002)
- Drumoak AB31 5EP, GB (2002)
- Schilde, BE (1996 - 2005)
- Drumoak, GB (2009)
Company Filing History:
Years Active: 1996-2009
Title: **Frank Christopher Odds: A Pioneer in Mycobacterial Research**
Introduction
Frank Christopher Odds is a prominent inventor located in Schilde, Belgium, with an impressive portfolio of 9 patents. His work mainly focuses on developing novel therapeutics for the treatment of mycobacterial diseases, showcasing his significant contributions to pharmaceutical science.
Latest Patents
Among his latest inventions, one notable patent is related to mycobacterial inhibitors. This invention involves novel substituted quinoline derivatives, which can significantly aid in treating mycobacterial infections. Specifically, the claimed compounds are designed to tackle diseases caused by pathogenic mycobacteria, possessing varying structural elements that enhance their pharmacological properties.
Another groundbreaking patent by Odds highlights compositions that employ an antifungal combined with a phospholipid for body and hair cleansing products. These innovative formulations, particularly shampoos, incorporate an antifungal that inhibits ergosterol biosynthesis, working alongside a synthetic phospholipid that serves as both a second active ingredient and a surfactant.
Career Highlights
Frank Christopher Odds has made substantial contributions throughout his career by registering several patents that demonstrate his expertise in pharmaceutical innovations. Working at Janssen Pharmaceutica, a notable company in the field of healthcare, he developed crucial solutions aimed at addressing various health challenges.
Collaborations
During his career, Odds collaborated with esteemed professionals such as Jan Heeres and Roger Carolus Augusta Embrechts. These partnerships have likely enriched his research and developments, fostering an environment of knowledge exchange and innovation.
Conclusion
Frank Christopher Odds stands out as a dedicated inventor whose work in developing strategies to combat mycobacterial diseases and innovating cleansing products underlines his impact in the pharmaceutical industry. His contributions continue to pave the way for future advancements in medical treatments and health solutions.